News & Press Releases

Enamine is announcing today the expansion of its Purification and Analytical Units to enable synthesis of 30 000 high quality screening library compounds monthly. Such expansion represents the largest development to date of its library synthesis capabilities.

Following the success since 2012 the collaboration with Sanofi aiming at finding of new valuable hit series in most challenging screening campaigns has been extended.

Collaboration with BioVersys AG aiming at discovery of novel treatments against bacterial infections has been extended for the 4th consecutive year.

Mykhailiuk, P. K. Generation of C₂F₅CHN₂ In Situ and Its First Reaction: [3+2] Cycloaddition with Alkenes Chem. Eur. J. 2014, 17, 5168. (Back Cover Picture)

Ritter, S. K. Diazoalkane Expands Fluorine Focus On Ethyl Groups Chemical & Engineering News, 92 (17), 2014.

Developing new methods for introducing fluorine into complex organic molecules has been all the rage during the past few years. Researchers preparing drug candidates and crop-protection chemicals typically seek to add a single fluorine atom or trifluoromethyl group and now have myriad ways to do so. But methods for adding longer, more lipophilic perfluoroalkyl groups, such as pentafluoroethyl, –C₂F₅, to complex molecules are relatively scarce. The approaches tend to be direct additions of C₂F₅ using organometallic transfer reagents and don’t utilize C₂F₅-containing building blocks.

Enamine scientists have developed a new building block for introducing C₂F₅ group into organic molecules. Pavel Mykhailiuk and colleagues safely generated the fluorinated diazoalkane, C₂F₅CHN₂, in situ from C₂F₅CH₂NH₂•HCl and NaNO₂. Authors demonstrated the utility of the reagent by using it in [3 + 2]-cycloadditions with mono- and disubstituted alkenes at room temperature to prepare perfluoroethylated pyrazolines with better than 95% conversion rates. Authors believe the diazofluoroalkane will also be as useful as other diazoalkanes for cyclopropanations, carbene insertions, and alkyne cycloadditions.

Controlling Biological Activity with Light: Diarylethene-Containing Cyclic Peptidomimetics
Oleg Babii, Sergii Afonin, Marina Berditsch, Sabine Reisser, Pavel K. Mykhailiuk, Vladimir S. Kubyshkin, Thomas Steinbrecher, Anne S. Ulrich and Igor V. Komarov
Angewandte Chemie International Edition 2014 53 (13), 3392–3395

Enamine scientists in collaboration with research at Karlsruhe Institute of Technology (KIT, Germany) published a study on antibiotics activated by light. It deals with synthesis of analogues of the antimicrobial peptide gramicidin S which conformations can be switched by light. This property was rendered by incorporation in its structure of an amino acid designed based on a photoisomerizable diarylethene scaffold. The biological activity of the resulting peptidomimetics can be reversibly controlled by ultraviolet/visible light.

Success of Enamine’s innovative product pipeline and service portfolio is based on the commitment of the company to the scientific research. Enamine caries out and supports research projects within the company as well as off-site in collaboration with many academic centers in Ukraine and abroad. About 30 scientific papers were published by Enamine scientists in renowned scientific journals in 2013.

336 Azides and alkynes have been selected from Enamine’s catalog of over 90 000 Building Blocks. Their structures have been published in the Selected Building Block series. This brochure, the sixth in series, provides a useful guide to novel and innovative chemistry developed at Enamine that can find multiple applications in drug design. Cycloaddition reaction of azides and alkynes has been shown to smoothly provide excellent yields of 1,2,3-triazoles. It has been recognized as an outstanding example of “click chemistry” This reaction can be used to selectively synthesize both 1,4- and 1,5-substituted triazoles. Besides reaction with azides alkynes undergo many other cycloaddition reactions.

With development of on-line chemical directories acquiring necessary reagents and building blocks for day-to-day research activity has become a technical routine. Many thousands of building blocks are now available in the market and sub-structure search can efficiently provide a selection of reagents to buy. However, this approach might be limited. With over 80,000 building blocks synthesized and now available from our stock we are a recognized leader in the market. Our catalog features versatile building block classes and adds 1,000 products each month. Although they all are available for purchase through EnamineStore and many public or corporate chemical databases we wanted to gather together the most interesting and recently prepared building blocks to provide a series of useful guides to a novel and innovative chemistry. First five brochures have been published to highlight our rich collections of Advanced Morpholine Analogues, Bicyclic Aliphatic Amines, Fluorinated Aliphatic Amines, Isocyanates, Isothiocyanates, and Trifluoroethyl Carbamates, and Sulfonyl Chlorides and other Sulfonylating Agents.

The new version of EnamineStore provides enhanced functionality to quickly search and purchase from catalogs of Enamine and UORSY (collectively over 10 million compounds). The following improvements have been realized besides changes in general form layouts:

Search functionality

• one search form with multiple usage modes for both easy and advanced queries introduced;
• JME replaced with Marvin JavaScript drawing tool, allowing to draw structures for queries conveniently in all modern web-browsers instead of resource-consuming Java applet;
• support of advanced query features introduced (multiple fragments, lists of atoms, generic query atoms, etc.);
• structure can be imported directly into the query editor;
• structural search history kept for the session;
• search by any supported structure identifier (Enamine catalog number, CAS/ ACD number or chemical name) or their list instantly introduced;
• new additional parameters can be added to building block queries: price limit and regional stock availability;
• found structures can be refined with a consecutive search using two different modes.

Catalog

• one-click search of close analogs, relevant by functional groups introduced;
• one-click transfer of structure to query builder introduced;
• building block prices visible directly in catalog (no need to put an item to cart to check price);
• transport conditions data added;
• added data export in tabular form (.csv format), export-related bugs fixed;
• information provided in a more user-friendly manner;
• consistent handling of screening compounds featuring multiple batches with different salt parts introduced.

Cart

• any item can be purchased in multiple different batches;
• salt part may be selected for screening compounds (whenever option available);
• inquiries for out-of-stock items are handled through cart and checkout as a part of ordering process.

Axxam S.p.A., a contract research and discovery company, announced today that an entirely new generation screening collection is now available for drug discovery programs: AXX^DIV2.0 made up with 240 000 carefully selected small molecules.

Four Ukrainian students won respectively three Gold medals and one Bronze medal at the 45th Chemistry Olympiad held in Moscow on July 15-24, 2013.
The Ukrainian Team competed against 291 students from 73 countries.

Members of Ukrainian Olympic team:

Andriy Stelmakh, Lviv Physics and Mathematics Lyceum – Gold Medal
Oleksandr Vyhivsky, Kharkiv school # 47 – Gold Medal
Mykyta Onizhuk, Kharkiv technical school # 173 – Gold Medal
Khrystofor Khokhlov, Kiev school # 145 – Bronze Medal

Enamine is continuously aiming towards excellence, in its organization, products & services. The company is proud of the achievement of the Ukrainian team and to have sponsored its national team. Sponsoring such event is a natural initiative from Enamine and we would like to warmly congratulate the four students for their results.

Source: Korresponsent.net

Enamine and Exquiron are announcing a multi-year collaboration wherby Exquiron is acquiring a large screening compounds libraries from Enamine.

3D Diversity Set from Enamine, containg 50 000 drug-like compounds, has been selected by ChanTest for their dicovery services using powerful HTS of Ion Channels, GPCRs and Transporters in partnership with pharma and biotech companies.

A collaboration agreement has been signed between Enamine, the Medical Research Council Laboratory of Molecular Biology (MRC LMB), Cambridge, UK, and the Institute of Organic Chemistry and Biochemistry of the Academy of Sciences of the Czech Republic (IOCB), Prague, Czech Republic. The new alliance is aimed at discovering novel Rhomboid Protease inhibitors as potential drugs to treat infectious, parasitic, oncological, immune and cardiovascular diseases. Enamine will provide the MRC LMB and IOCB with access to its integrated drug discovery capabilities, including Molecular Modeling, Compound Library, Screening Assays, Hit Finding and Characterization, Hit to Lead Chemistry and ADMET. The three parties will seek to partner the small molecule inhibitors generated with pharmaceutical companies for onward clinical development. The collaboration agreement was negotiated by MRC Technology on behalf of MRC LMB.

Recently several new features were made available to users of EnamineStore:

• card payments are enabled for all pending invoices issued by Enamine for both on-line and off-line orders – now it is possible to securely pay any outstanding invoice with credit card in the Billing section
• storage conditions, regional stock availabilities, MDL reference numbers and chemical names are displayed for Building Blocks
• lists of MDL numbers can be searched using the Search Wizard
• sample certificates of analysis and material safety data sheets for building blocks can be downloaded from the catalog instead of plain analytical data provided before
• Rush delivery can be requested for a building block being ordered on-line (subject to regional availability)

Enamine and UkrOrgSynthesis Ltd (UORSY), a leading Ukrainian supplier of chemical building blocks and compounds for high-throughput screening, announced they have signed a collaboration agreement to offer chemical building blocks to the drug discovery industry cooperatively. By combining their catalogues, the companies become the largest global manufacturer and seller of building blocks, with 60 000 products available from stock for immediate delivery and an array of ca. 8 million tangible building blocks deliverable with synthetic success rate of 80%.

Enamine Ltd concluded an agreement with Legend Star International Co., to further promote products offered by Enamine to Taiwan drug discovery market. It is expected, that Taiwanese customers will be getting all relevant information on Enamine compounds and services from the local distributor and will benefit from improved service. Clients from Taiwan are encouraged to contact Legend Star International Co., Ltd. for all questions related to purchase of Enamine products:
1F., No.166, Fuxing 3rd St.,
Taishan Township, Taipei, Taiwan,
Mr. Chen Tsung-Ting
Tel: 886-2-29003199 (Ext 20)
Fax: 886-2-29009912
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Enamine Ltd, a leading provider of screening compounds and chemical building blocks, today announced it has extended its long-standing relationship with BioFocus, with the acquisition by BioFocus of a large new compound screening library. The library will be available to BioFocus HTS collaborators in early 2012.

Enamine announces opening of contract biology laboratory at its main research site in Kyiv, Ukraine. Enamine’s BioLab will be providing ADMET (absorption, distribution, metabolism, excretion and toxicity) and biomolecular screening services to expand Enamine’s chemistry-driven CRO capabilities into the biological support of early phase drug discovery projects.

Integration of the newly created contract biology lab with Enamine’s internationally renowned synthetic chemistry powerhouse and the vast screening compound repository creates a perfect combination for providing efficient and cost-competitive drug discovery services to the international pharmaceutical and biotech industry.

Enamine is planning to change the numbering of products offered through screening collections in 2012. To facilitate compound tracking in different offerings and allow transparent identification of structures by their unique ID throughout various databases, the old identification method utilizing lot-related T-numbers will be ceased. According to the new identification system all structures referring to compounds offered by Enamine for screening will have unique Z-codes familiar to those who worked with REAL Database before. Existing T-codes will be supported for ordering purposes.

Solid-Phase Peptide Synthesis was launched by Enamine with a new PS3 Peptide synthesizer (Protein Technologies, Inc.). Small linear and cyclic peptides comprising 2 to 25 amino acid residues of both natural and unnatural origin can be prepared on 1-30 mg scale in a highly pure form (>95%). A large collection of proprietary unnatural amino acids including many conformationally constrained ones as well as ones containing fluorine substituents can be used to expand the variety of peptides. The example structures of peptides prepared with our new peptide synthesizer are listed below.

CF3-Labeled Gramicidin-S analogue ( Angew.Chem., Int. Ed. Engl . 2006 , 45 , 5659-5661)	Cell-penetrating peptide SAP-E ( ChemBioChem 2011, 12 , 896-903)
CF3-Labeled SAP analogue ( Angew. Chem. Int. Ed. 2008 , 47 , 5765 –5767 )